72
Participants
Start Date
April 30, 2014
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
CaCP29
Placebo
Study Site, Aachen
Study Site, Augsburg
Study Site, Bad Saarow
Study Site, Berlin
Study Site, Göttingen
Study Site, Greifswald
Study Site, Hamburg
Study Site, Jena
Study Site, Kiel
Study Site, Leipzig
Study Site, Oldenburg
Lead Sponsor
InflaRx GmbH
INDUSTRY